Advertisement

Topics

Merck & Co Company Profile

20:28 EDT 16th July 2018 | BioPortfolio

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. We highlight the company's key figures. We explain the history of the name "Merck" and the two companies operating under this name today. We show Merck's visions for the future and guide you through over three hundred years of company history.

Location

Frankfurter Str. 250
Darmstadt
64293
Germany

Contact

Phone: +49 6151 72-0
Fax: +49 6151 72 2000
Email: webmaster@merck.de


News Articles [883 Associated News Articles listed on BioPortfolio]

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

Merck: Verkauf wird positiv aufgenommen

Die Analysten von Independent Research bestätigen die Halteempfehlung für die Aktien von Merck. Das Kursziel für die Papiere von Merck sehen die Experten weiter bei 88,00 Euro. Die jüngsten Entwic...

Merck posts strong first-quarter profit, but revenue light

In this Dec. 18, 2014, file photo, a person walks through a Merck company building, in Kenilworth, N.J. Merck & Co. reports earnings Tuesday, May 1, 2018.

MERCK IM FOKUS: Ein Jubiläumsjahr in Darmstadt zwischen Hoffen und Bangen

FRANKFURT (dpa-AFX Broker) - Wie ist die Lage bei Merck? Die wichtigsten Punkte für das Unternehmen, was die Experten sagen und wie es für die Aktie läuft: DAS IST LOS BEI MERCK Aus einer altehrwü...

Little Exonics Adds Merck's Larger-Than-Life R&D Chief to Its Board of Directors

Since 2013, Dr. Perlmutter has served as executive vice president of Merck and president of Merck Research Laboratories.

IO Biotech studies NSCLC combo treatment with Merck

IO Biotech ApS and Merck &Co. Inc. will together conduct a Phase I/II trial studying the combination of IO’s investigational IO102 with Merck’s Keytruda (pembrolizumab) for metastatic non-small ce...

Merck KGaA zuversichtlich, Analyst mit Kaufempfehlung: Aktie nimmt Kurs auf Widerstand

Der DAX-Konzern Merck KGaA will sein schwächelndes Geschäft mit Spezialmaterialien auf den Wachstumskurs zurückbringen. Der Unternehmensbereich bündelt das Spezialchemikaliengeschäft von Merck un...

Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer

Merck is making a $125 million investment in Moderna as part of a new funding round. "We're encourage by the potential for RNA-based vaccines," says Eric Rubin, a Merck vice president.

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Winners of the Emanuel Merck Lectureship and the Heinrich Emanuel Merck Award.

Treating MS without continuous immunosuppression: an interview with Luciano Rossetti.

Luciano Rossetti, MD, Executive Vice President, Global Head of R&D at Merck KGaA, Darmstadt, Germany speaks to Laura Dormer, Commissioning Editor Luciano Rossetti, MD, is Executive Vice President, Glo...

Merck vaccine heads Ebola countermeasures.

Japan Prize / Merck-Banyu Lectureship for Naoya Kumagai / DECHEMA Prize for Timothy Noël.

The Recipe for Corporate Longevity: From the Perspective of "Managing Innovation".

The elephant is in the room-a metaphorical idiom for an obvious problem or risk that nobody wants to discuss. This abstract is not intended to be a summary, to reveal major findings, or unveil conclus...

Clinical Trials [86 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt)

The study will assess the bioequivalence between single doses of GXR manufactured in Merck Nantong China (test drug) and GXR manufactured in Merck Darmstadt Germany (reference drug) under ...

Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study

The purpose of this study is to assess bioequivalence between metformin hydrochloride (Glucophage® XR) manufactured in PT Merck Tbk, Indonesia (test drug) and metformin hydrochloride (Glu...

Companies [137 Associated Companies listed on BioPortfolio]

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "Merck & Co" on BioPortfolio

We have published hundreds of Merck & Co news stories on BioPortfolio along with dozens of Merck & Co Clinical Trials and PubMed Articles about Merck & Co for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck & Co Companies in our database. You can also find out about relevant Merck & Co Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record